Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Trotana Therapeutics

trotana.com ↗

Clinical Phase 1

Profile checked Oct 10, 2026

Keywords: TRT-448

1Trials (company is sponsor)

Timeline

Aug 30, 2026 Trial start 1: Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects source ↗

Upcoming milestones

Apr 1, 2027 (ESTIMATED) · 1 · Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects · NCT07745751

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07745751	Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects	1	Not yet recruiting	Aug 30, 2026	Apr 1, 2027 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of ARCH Venture Partners (captured Oct 12, 2026). portfolio page ↗